Association between testosterone and estradiol and age-related decline in physical function in a diverse sample of men

Journal of the American Geriatrics Society

Volumn 56, Issue 11, 2008, Pages 2000-2008

  Araujo, Andre B ^a   Travison, Thomas G ^a   Bhasin, Shalender ^b   Esche, Gretchen R ^a   Williams, Rachel E ^c   Clark, Richard V ^c   McKinlay, John B ^a  

^a NEW ENGLAND RESEARCH INSTITUTES   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

Aging; Androgens; Body composition; Estrogens; Men; Physical function; Population studies

Indexed keywords

ESTRADIOL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; AGING; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; GRIP STRENGTH; HUMAN; HUMAN CELL; LEAN BODY WEIGHT; MALE; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PHYSICAL CAPACITY; TESTOSTERONE BLOOD LEVEL; WALKING SPEED;

ADULT; AGED; AGING; BODY COMPOSITION; CROSS-SECTIONAL STUDIES; ESTRADIOL; HAND STRENGTH; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PHYSICAL ENDURANCE; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 55349123630     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2008.01965.x     Document Type: Article

References (56)

1. Baumgartner RN. Body composition in healthy aging. Ann N Y Acad Sci 2000 904 : 437 448.
2. Roubenoff R, Hughes VA. Sarcopenia: Current concepts. J Gerontol A Biol Sci Med Sci 2000 55A : M716 M724.
3. Feldman HA, Longcope C, Derby CA et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: Longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2002 87 : 589 598.
4. Harman SM, Metter EJ, Tobin JD et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001 86 : 724 731.
5. Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005 26 : 833 876.
6. Orwoll E, Lambert LC, Marshall LM et al. Testosterone and estradiol among older men. J Clin Endocrinol Metab 2006 91 : 1336 1344.
7. Mohr BA, Bhasin S, Kupelian V et al. Testosterone, sex hormone-binding globulin, and frailty in older men. J Am Geriatr Soc 2007 55 : 548 555.
8. Roy TA, Blackman MR, Harman SM et al. Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men. Am J Physiol Endocrinol Metab 2002 283 : E284 E294.
9. Schaap LA, Pluijm SM, Smit JH et al. The association of sex hormone levels with poor mobility, low muscle strength and incidence of falls among older men and women. Clin Endocrinol (Oxford) 2005 63 : 152 160.
10. Szulc P, Claustrat B, Marchand F et al. Increased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: The MINOS Study. J Clin Endocrinol Metab 2003 88 : 5240 5247.
11. Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR et al. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: A randomized controlled trial. JAMA 2008 299 : 39 52.
12. Snyder PJ, Peachey H, Hannoush P et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 1999 84 : 2647 2653.
13. Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992 75 : 1092 1098.
14. Wang C, Eyre DR, Clark R et al. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men - a clinical research center study. J Clin Endocrinol Metab 1996 81 : 3654 3662.
15. Wang C, Swerdloff RS, Iranmanesh A et al. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab 2000 85 : 2839 2853.
16. Araujo AB, Travison TG, Harris SS et al. Race/ethnic differences in bone mineral density in men. Osteoporos Int 2007 18 : 943 953.
17. McKinlay JB, Link CL. Measuring the urologic iceberg: Design and implementation of the Boston Area Community Health (BACH) Survey. Eur Urol 2007 52 : 389 396.
18. Washburn RA, Smith KW, Jette AM et al. The Physical Activity Scale for the Elderly (PASE): Development and evaluation. J Clin Epidemiol 1993 46 : 153 162.
19. Södergard R, Backstrom T, Shanbhag V et al. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 1982 16 : 801 810.
20. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999 84 : 3666 3672.
21. Guralnik JM, Simonsick EM, Ferrucci L et al. A short physical performance battery assessing lower extremity function: Association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994 49 : M85 M94.
22. Cochran WG. Sampling Techniques, 3rd Ed. New York : John Wiley & Sons, 1977.
23. Wood S. Generalized Additive Models: An Introduction with R. Boca Raton : Chapman and Hall, 2006.
24. O'Donnell AB, Travison TG, Harris SS et al. Testosterone, dehydroepiandrosterone, and physical performance in older men: Results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2006 91 : 425 431.
25. Wright S. The method of path coefficients. Ann Math Statist 1934 5 : 161 215.
26. Muthen LK, Muthen BO. Mplus User's Guide, 4th Ed. Los Angeles : 2006.
27. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr 1974 19 : 716 723.
28. Bhasin S, Calof OM, Storer TW et al. Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nat Clin Pract Endocrinol Metab 2006 2 : 146 159.
29. Singh R, Artaza JN, Taylor WE et al. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: Nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 2006 147 : 141 154.
30. Brodsky IG, Balagopal P, Nair KS. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men - a clinical research center study. J Clin Endocrinol Metab 1996 81 : 3469 3475.
31. Ferrando AA, Sheffield-Moore M, Yeckel CW et al. Testosterone administration to older men improves muscle function: Molecular and physiological mechanisms. Am J Physiol Endocrinol Metab 2002 282 : E601 E607.
32. Cesari M, Penninx BW, Pahor M et al. Inflammatory markers and physical performance in older persons: The InCHIANTI Study. J Gerontol A Biol Sci Med Sci 2004 59A : 242 248.
33. Kapoor D, Clarke S, Stanworth R et al. The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. Eur J Endocrinol 2007 156A : 595 602.
34. Maggio M, Basaria S, Ble A et al. Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men. J Clin Endocrinol Metab 2006 91 : 345 347.
35. Page ST, Herbst KL, Amory JK et al. Testosterone administration suppresses adiponectin levels in men. J Androl 2005 26 : 85 92.
36. Baumgartner RN, Waters DL, Gallagher D et al. Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev 1999 107 : 123 136.
37. Bhasin S, Storer TW, Berman N et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 1996 335 : 1 7.
38. Kenny AM, Prestwood KM, Gruman CA et al. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 2001 56A : M266 M272.
39. Storer TW, Magliano L, Woodhouse L et al. Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension. J Clin Endocrinol Metab 2003 88 : 1478 1485.
40. Page ST, Amory JK, Bowman FD et al. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 2005 90 : 1502 1510.
41. Schaap LA, Pluijm SM, Deeg DJ et al. Low testosterone levels and decline in physical performance and muscle strength in older men: Findings from two prospective cohort studies. Clin Endocrinol (Oxford) 2008 68 : 42 50.
42. Taaffe DR, Cooper CS, Holloway L et al. Lack of association of anabolic hormone status and muscle strength with regional and whole body bone mineral density in healthy men aged 60-79 years. Aging (Milano) 1999 11 : 4 11.
43. Bhasin S, Woodhouse L, Casaburi R et al. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab 2005 90 : 678 688.
44. Nair KS, Rizza RA, O'Brien P et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 2006 355 : 1647 1659.
45. Snyder PJ, Peachey H, Berlin JA et al. Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 2000 85 : 2670 2677.
46. Jones ME, Boon WC, McInnes K et al. Recognizing rare disorders: Aromatase deficiency. Nat Clin Pract Endocrinol Metab 2007 3 : 414 421.
47. Orwoll E, Lambert LC, Marshall LM et al. Endogenous testosterone levels, physical performance, and fall risk in older men. Arch Intern Med 2006 166 : 2124 2131.
48. van den Beld AW, de Jong FH, Grobbee DE et al. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab 2000 85 : 3276 3282.
49. Visser M, Deeg DJ, Lips P et al. Skeletal muscle mass and muscle strength in relation to lower-extremity performance in older men and women. J Am Geriatr Soc 2000 48 : 381 386.
50. Ly LP, Jimenez M, Zhuang TN et al. A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. J Clin Endocrinol Metab 2001 86 : 4078 4088.
51. Sternfeld B, Ngo L, Satariano WA et al. Associations of body composition with physical performance and self-reported functional limitation in elderly men and women. Am J Epidemiol 2002 156 : 110 121.
52. Baumgartner RN, Wayne SJ, Waters DL et al. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res 2004 12 : 1995 2004.
53. Roubenoff R. Sarcopenic obesity: Does muscle loss cause fat gain? Lessons from rheumatoid arthritis and osteoarthritis. Ann N Y Acad Sci 2000 904 : 553 557.
54. US General Accounting Office. Report to Congressional Requesters. SSA Disability: Other Programs May Provide Improving Return to Work Efforts. GAO-01-153. Washington, DC, 2000.
55. Cawthon PM, Marshall LM, Michael Y et al. Frailty in older men: Prevalence, progression, and relationship with mortality. J Am Geriatr Soc 2007 55 : 1216 1223.
56. Ensrud KE, Ewing SK, Taylor BC et al. Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med 2008 168 : 382 389.